settle in cash
convert into shares
CFO mandate · capital structure
bid below $1.00 · cure pending
70% convert
Convertible note, cash runway, and the Nasdaq bid-price loop
funds
Convertible note
senior secured
CFO steers mix
Conversion
debt to shares
Settle in cash
drains runway
Dilution
share count climbs
bid falls
$1.00
Nasdaq
bid price
now
cure window
Dec 28 2026
regains $1.00
deadline passes
Bid recovered
controlled dilution
Threshold unmet
shares mount · delisting
feedback
funding loop
Cash runway
minimal